The Liver Disease Panel includes LiverPRO—a certified algorithm developed by the health tech company Evido—requiring only age and routine blood markers for the timely detection of liver fibrosis With ...
Chronic liver disease poses a growing global health burden, driven in large part by metabolic risk factors and viral hepatitis. Fibrosis stage is the principal ...
Non-invasive biomarkers and scoring systems demonstrated effectiveness in differentiating chronic liver disease (CLD) from cirrhosis; non-invasive fibrosis scores such as the Lok index, King's score, ...
Non-invasive indicators of liver fibrosis could help with risk stratification for heart failure. The median follow-up duration was 10.7 years. For all three measures of liver fibrosis, the risk for ...
Roche announced the launch of its comprehensive Liver Disease Panel, a suite of certified algorithms designed to help clinicians better identify and manage chronic liver disease (CLD). By bringing ...
Doctors at the Cleveland Clinic are using a new non-invasive technique to treat liver cancer, offering a promising alternative to traditional treatments like surgery and chemotherapy, which often come ...
Focused ultrasound creates precise mechanical cavitation that liquefies tumor tissue while sparing adjacent parenchyma, avoiding thermal sink effects and reducing risk near major vessels and bile ...
SHREVEPORT, La. - Patients diagnosed with liver cancer in the ArkLaTex now have access to a new treatment option closer to home. Willis-Knighton Health System is now offering Histotripsy, a newly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results